Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Comparison of Standard-Dose Versus Fixed-Dose Rituximab for Non-Malignant, Immune-Mediated Hematologic Disorders

Raj S. Kasthuri, Ryan Kemper, Brittany Holshouser, Elizabeth Powell, Allison B Carroll, Sheh-Li Chen, Daniel Crona, Lee Ann Jones

Blood (2024) 144 (Supplement 1): 1237.

https://doi.org/10.1182/blood-2024-210540

Published: 2024

Journal Articles

PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life

Blood (2023) 142 (Supplement 2): LBA-3.

https://doi.org/10.1182/blood-2023-191983

Published: 2023

Journal Articles

Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge from the Hospital Is Not Associated with an Improvement in Quality of Life: Results from the Activ 4c Clinical Trial

Lisa Baumann Kreuziger, Taeim Kwon, Lana Wahid, Raj S. Kasthuri, Andrei L. Kindzelski, M. Margaret Knudson, Jerry Krishnan, Gervasio Lamas, Eric Leifere, Jose Lopez-Sendon, Peter J Miller, Bela Patel, Alexandra J Weissman, John Quigley, Deborah Siegal, Tracy Y Wang, Kevin J Anstrom, Thomas L. Ortel

Blood (2023) 142 (Supplement 1): 2630.

https://doi.org/10.1182/blood-2023-190552

Published: 2023

Journal Articles

Establishment and Utilization of an Advanced Practice Provider-Led Clinic for Newly Diagnosed Venous Thromboembolism

Cassiopeia Frank, Nigel S. Key, Micah J. Mooberry, Raj S. Kasthuri, Stephan Moll

Blood (2022) 140 (Supplement 1): 7887–7888.

https://doi.org/10.1182/blood-2022-170183

Published: 2022

Journal Articles

Race, rituximab, and relapse in TTP

Blood (2022) 140 (12): 1335–1344.

https://doi.org/10.1182/blood.2022016640

Published: 2022

Includes: Supplemental data

Journal Articles

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

Blood (2019) 134 (Supplement_1): 1066.

https://doi.org/10.1182/blood-2019-131064

Published: 2019

Journal Articles

An International Multicenter Study of Intravenous Bevacizumab for the Treatment of Chronic Bleeding and Anemia in Hereditary Hemorrhagic Telangiectasia: The Inhibit-Bleed Study

Hanny Al-Samkari, MD, Raj S. Kasthuri, MD, Hasan A. Albitar, MD, Yahya Almodallal, MBBS, Marcelo M. Serra, MD, Carolina Vazquez, MD, Sophie Dupuis-Girod, MD PhD, Clifford R. Weiss, MD, Muhammad A. Latif, MD, Mary Elizabeth Meek, MD, David J. Kuter, Vivek N. Iyer, MD MPH

Blood (2019) 134 (Supplement_1): 1060.

https://doi.org/10.1182/blood-2019-129418

Published: 2019

Journal Articles

Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations

Blood (2019) 134 (Supplement_1): 90.

https://doi.org/10.1182/blood-2019-129383

Published: 2019

Journal Articles

Recombinant Porcine FVIII in Acquired Hemophilia: Decreased Product Usage When Used Upfront, Non-Utility of Baseline Porcine Bethesda Titer, and Confirmation of Dosing Algorithm

Patrick Ellsworth, MD, Sheh-Li Chen, PharmD, Nigel S. Key, MBChB, FRCP, Raj S. Kasthuri, MD, Micah J. Mooberry, MD, Alice D. Ma, MD

Blood (2018) 132 (Supplement 1): 2474.

https://doi.org/10.1182/blood-2018-99-118839

Published: 2018

Journal Articles

Causes and Severity of Anemia in Hereditary Hemorrhagic Telangiectasia

Kristy Pahl, MD, Arkopal Choudhury, Raj S. Kasthuri, MD MBBS

Blood (2016) 128 (22): 3776.

https://doi.org/10.1182/blood.V128.22.3776.3776

Published: 2016

Journal Articles

Effect of Genotype and Antifibrinolytic Therapy on the Severity of Epistaxis in Hereditary Hemorrhagic Telangiectasia

Joan Beckman, MDPhD, Karen L Smith, BS, Samuel T Hester, MD, Ofri Leitner, MS, CGC, Raj S. Kasthuri, MD MBBS

Blood (2014) 124 (21): 1515.

https://doi.org/10.1182/blood.V124.21.1515.1515

Published: 2014

Journal Articles

PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI

Raj S. Kasthuri, Sam L. Glover, William Jonas, Troy McEachron, Rafal Pawlinski, Gowthami M. Arepally, Nigel S. Key, Nigel Mackman

Blood (2012) 119 (22): 5285–5293.

https://doi.org/10.1182/blood-2011-06-359430

Published: 2012

Journal Articles

Single Center Experience with Rituximab as First Line Immunosuppression Regimen for Acquired Hemophilia

Jeremiah Boles, MD, Nigel S. Key, MBChB, Raj S. Kasthuri, MD, MBBS, Alice D. Ma, MD

Blood (2010) 116 (21): 1419.

https://doi.org/10.1182/blood.V116.21.1419.1419

Published: 2010

Journal Articles

Anthracycline Treatment of the Monocytic Leukemia Cell Line THP-1 Increases Phosphatidylserine Exposure and Tissue Factor Activity.

Jeremiah Boles, MD, Sam Glover, BS, A. Phillip Owens, III, PhD, Rachel Hollingsworth, Raj S. Kasthuri, MD, MBBS, Nigel S. Key, MBChB, Nigel Mackman, PhD

Blood (2010) 116 (21): 1136.

https://doi.org/10.1182/blood.V116.21.1136.1136

Published: 2010

Journal Articles

Characterization of Receptors Involved in Heparin Antibody Complex Mediated Induction of Tissue Factor Expression in Monocytes.

Sam Glover, BS, Nigel S. Key, MBChB, Gowthami M Arepally, MD, Nigel Mackman, PhD, Raj S. Kasthuri, MD, MBBS

Blood (2009) 114 (22): 224.

https://doi.org/10.1182/blood.V114.22.224.224

Published: 2009

Journal Articles

Spectrum of Antiphospholipid Antibodies and Associated Thrombotic and Obstetric Events among Patients with Antiphospholipid Syndrome

Mrinal M Patnaik, MD, Kitsada Wudhikarn, M.D., Monal M Shroff, PhD, Anthony A Killeen, MD, Mark T. Reding, MD, Raj S. Kasthuri, MD, MBBS

Blood (2008) 112 (11): 5343.

https://doi.org/10.1182/blood.V112.11.5343.5343

Published: 2008

Journal Articles

Proteomics in the Study of Qualitative Platelet Defects: Validation of the Approach in the Gray Platelet Syndrome and Quebec Platelet Disorder.

Raj S. Kasthuri, MBBS, Lorraine B. Anderson, PhD, LeeAnn Higgins, PhD, Jorge Di Paola, MD, Georges E. Rivard, MD, FRCP(C), Catherine P.M. Hayward, MD, PhD, FRCP(C), Nigel S. Key, MB, FRCP

Blood (2007) 110 (11): 3900.

https://doi.org/10.1182/blood.V110.11.3900.3900

Published: 2007

Journal Articles

Sepsis Following Parenteral Sodium Ferric Gluconate Complex Infusion: A Report of Two Cases and Literature Review.

Tufia C. Haddad, MD, Raj S. Kasthuri, MBBS, Gregory M. Vercellotti, MD

Blood (2006) 108 (11): 3729.

https://doi.org/10.1182/blood.V108.11.3729.3729

Published: 2006

Journal Articles

Plasma Proteome Profiling: Widespread Oxidative Changes in Endotoxemia Correlate with Intravascular Tissue Factor Response.

Raj S. Kasthuri, M.D., Jessica L. Hysjulien, Laura E. Norton, Tyson Rogers, M.S., Bernd Jilma, M.D., Nigel S. Key, M.D., Gary L. Nelsestuen, PhD

Blood (2004) 104 (11): 2388.

https://doi.org/10.1182/blood.V104.11.2388.2388

Published: 2004

NARROW

Comparison of Standard-Dose Versus Fixed-Dose Rituximab for Non-Malignant, Immune-Mediated Hematologic Disorders

PATH-HHT, a Double-Blind, Randomized, Placebo-Controlled Trial in Hereditary Hemorrhagic Telangiectasia Demonstrates That Pomalidomide Reduces Epistaxis and Improves Quality of Life

Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge from the Hospital Is Not Associated with an Improvement in Quality of Life: Results from the Activ 4c Clinical Trial

Establishment and Utilization of an Advanced Practice Provider-Led Clinic for Newly Diagnosed Venous Thromboembolism

Race, rituximab, and relapse in TTP

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

An International Multicenter Study of Intravenous Bevacizumab for the Treatment of Chronic Bleeding and Anemia in Hereditary Hemorrhagic Telangiectasia: The Inhibit-Bleed Study

Differential Effect of Rituximab on Relapse-Free Survival in De Novo and Relapsed Immune Thrombotic Thrombocytopenic Purpura in African-American and Caucasian Populations

Recombinant Porcine FVIII in Acquired Hemophilia: Decreased Product Usage When Used Upfront, Non-Utility of Baseline Porcine Bethesda Titer, and Confirmation of Dosing Algorithm

Causes and Severity of Anemia in Hereditary Hemorrhagic Telangiectasia

Effect of Genotype and Antifibrinolytic Therapy on the Severity of Epistaxis in Hereditary Hemorrhagic Telangiectasia

PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI

Single Center Experience with Rituximab as First Line Immunosuppression Regimen for Acquired Hemophilia

Anthracycline Treatment of the Monocytic Leukemia Cell Line THP-1 Increases Phosphatidylserine Exposure and Tissue Factor Activity.

Characterization of Receptors Involved in Heparin Antibody Complex Mediated Induction of Tissue Factor Expression in Monocytes.

Spectrum of Antiphospholipid Antibodies and Associated Thrombotic and Obstetric Events among Patients with Antiphospholipid Syndrome

Proteomics in the Study of Qualitative Platelet Defects: Validation of the Approach in the Gray Platelet Syndrome and Quebec Platelet Disorder.

Sepsis Following Parenteral Sodium Ferric Gluconate Complex Infusion: A Report of Two Cases and Literature Review.

Plasma Proteome Profiling: Widespread Oxidative Changes in Endotoxemia Correlate with Intravascular Tissue Factor Response.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only